While targeted treatments emerge continuously, the insurance benefit causes difficulties in the market
While many pharmaceutical companies had focused on the development of chronic disease treatments, such as hypertension and diabetes, in early-2000s, the latest new drug trend is the R&D of targeted agents and rare disease treatments.
The reason why pharmaceutical companies have worked so hard on...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
